Aladin (Sildenafil)

Quick links

Choose a section

Quick links to important sections

Advertisements
Advertisements

Overview of Aladin (Sildenafil)

Quick Facts: Aladin (Sildenafil)

Property Description
Active ingredient Sildenafil (Sildenafil Citrate)
Primary Form Film-coated tablet (Oral dosage form)
Pharmacological class Phosphodiesterase type 5 (PDE5) Inhibitor
General Purpose Supports functions reliant on localized blood flow
Origin Synthetic compound

Defining Aladin (Sildenafil): Chemical Identity and Drug Class

Aladin is a prescription-only oral medication containing the active chemical substance Sildenafil, most often administered as the salt Sildenafil Citrate. This compound is structurally defined as a synthetic pyrazolopyrimidinone derivative. Functionally, Sildenafil belongs to the pharmacological class known as a Phosphodiesterase type 5 (PDE5) Inhibitor. Understanding its categorization as a selective PDE5 inhibitor is essential, as this defines the medication's inherent functional role in modulating vascular tone. Sildenafil is classified within this category, distinguishing it from general cardiovascular agents.

Pharmaceutical Form and Delivery Type

The medicinal preparation Aladin (Sildenafil) is typically presented as an oral dosage form, most commonly supplied as a film-coated tablet designed for systemic delivery following ingestion. The medication is structured as a single active ingredient product, ensuring that its pharmacological effect is derived solely from the action of Sildenafil. The film-coating represents a differentiating factor, designed to mask the taste and facilitate easy swallowing compared to non-coated forms. The active substance is also available for systemic use via other preparations, including a powder that is reconstituted for oral suspension.

Mechanism of Classification and General Purpose

The core functional purpose of Aladin (Sildenafil) is established by its mechanism as a selective PDE5 inhibitor, which promotes vasodilation in specific areas of the body. This classification means the drug's overall therapeutic utility is centered on facilitating a localized, sustained increase in blood flow where it is medically indicated. The inhibition of PDE5 leads to increased cGMP, resulting in smooth muscle relaxation and enhanced blood flow in the relevant tissues. The primary action involves supporting physiological functions that rely fundamentally on healthy, regulated vascular circulation, which is relevant to conditions associated with impaired vascular function.

Advertisements

What side effects are possible with Aladin (Sildenafil)?

Possible Side Effects and Safety Information

Aladin (Sildenafil) has a documented safety profile established through clinical studies and regulatory surveillance. The adverse reactions are classified by frequency and grouped by the physiological system affected, consistent with official regulatory documents like the EMA Summary of Product Characteristics (SmPC) and FDA Prescribing Information.

Frequency-Classified Adverse Reactions

The most frequently reported adverse reaction is headache, which is officially classified as Very Common. Other effects are classified as Common, including dizziness, facial flushing, nasal congestion, dyspepsia, and visual disturbances such as blurred vision or a colour tinge to vision. Reactions occurring with lower frequency, such as palpitations, skin rash, myalgia, and vomiting, are generally classified as Uncommon.


Serious Adverse Reactions and Safety Constraints

The official safety information documents rare, but clinically significant adverse reactions, including Non-arteritic anterior ischaemic optic neuropathy (NAION) (loss of vision) and Priapism (a prolonged erection lasting over four hours). Rare, serious cardiovascular events such as myocardial infarction and sudden cardiac death have also been reported in temporal association with use.

Safety constraints define specific limitations, most notably the absolute contraindication for use with any form of nitrates or other guanylate cyclase stimulators due to the risk of severe hypotension. Furthermore, use is generally restricted in individuals with a history of NAION or severe organ impairment, such as severe hepatic or renal dysfunction, as clearance of Sildenafil is officially documented to be reduced in these populations.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

An overdose of Aladin (Sildenafil) is officially documented to result in an increased frequency and severity of adverse effects already known at therapeutic doses, rather than generating new or unique symptoms. These intensified manifestations may affect the vascular and sensory systems, and include severe headache, flushing, nasal congestion, pronounced visual disturbances, or decreased blood pressure. Regulatory classification notes that exposure-related factors, such as doses exceeding the maximum recommended level, may lead to this symptom escalation.

Immediate Medical Assistance Required

The official regulatory documents mandate that emergency medical assistance must be sought immediately in the event of a specific, severe vascular outcome: Priapism, defined as an erection persisting longer than 4 hours. Failure to receive prompt treatment for priapism carries the risk of resulting in penile tissue damage and permanent loss of potency. Medical attention is also required for sudden decrease or loss of vision or sudden decrease or loss of hearing. Patients with severe renal or hepatic impairment are noted to have the potential for higher systemic exposure following an overdose due to reduced clearance.

Overdose Management

Management of a Sildenafil overdose is based on standard symptomatic and supportive treatment. Regulatory guidance explicitly notes that no specific antidote is known. Furthermore, due to the substance’s high protein binding, official information states that renal dialysis is not expected to accelerate the clearance of Sildenafil from the body.

Advertisements

Therapeutic Uses of Aladin (Sildenafil)

What Aladin (Sildenafil) Treats: Main Uses and Benefits

Sildenafil is commonly used to address conditions where symptoms linked to organ-specific functional stress create noticeable physiological strain. The medication's application spans therapeutic domains involving certain distressing symptoms and functional limitations.

The two main therapeutic applications include managing erectile dysfunction (ED) and addressing symptoms related to high pressure in the lung arteries, known as Pulmonary Arterial Hypertension (PAH).

Supporting Functional Stability

Aladin is commonly used for ED, which involves difficulty in the achievement or sustenance of a firm erection adequate for sexual activity, especially in conditions involving episodic or fluctuating manifestations, such as in patients with diabetes mellitus. The key therapeutic benefit is used for managing symptoms related to physical discomfort and may assist with functional stability for sexual activity, which contributes to easing the psychological burden.

For PAH, the medication is applied to manage symptoms like chronic dyspnea (shortness of breath) and fatigue that limit physical capacity. By addressing these symptoms, the medicine contributes to improved comfort during symptomatic periods and may assist with coping more steadily with functional strain in both adults and children.

Quick Fact: Relief for Functional Strain
Symptom Management Helps address groups of symptoms that may create noticeable functional strain.
Common Contexts Used in conditions involving episodic needs (ED) and conditions characterized by periods of heightened symptoms (PAH).
Patient Benefit Provides support that helps ease the overall symptom burden.

Regulatory References

  1. NIH MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Aladin (Sildenafil)?

The eligibility profile for Sildenafil is strictly defined by regulatory guidelines. Use is permitted for adults (18 years and older) for both approved indications. For Pulmonary Arterial Hypertension (PAH), use is also permitted in children aged 1 to 17 years. Use for Erectile Dysfunction (ED) is not indicated in individuals under 18 or in women.

The medicine is absolutely contraindicated in patients taking:

  • Any form of organic nitrates or Guanylate Cyclase stimulators.
  • Those with known hypersensitivity or a history of vision loss due to Non-arteritic anterior ischaemic optic neuropathy (NAION).
  • Those with severe cardiovascular conditions (e.g., recent stroke, myocardial infarction, severe hypotension).

Caution is required for restricted-use populations, including patients with severe hepatic or renal impairment, anatomical deformations of the penis, or conditions that predispose to priapism. Use is not recommended during pregnancy or lactation, as regulatory status is classified as unknown risk to the infant.

Advertisements

What should I know about interactions with other medicines?

Aladin (Sildenafil) has documented interactions with several categories of medicines, primarily due to its vasodilatory action and its metabolism pathway.

Contraindicated Combinations

Co-administration with nitrates or nitric oxide donors in any form (e.g., nitroglycerin, isosorbide mononitrate) is contraindicated due to the risk of severe and life-threatening hypotension, stemming from the potentiation of the nitric oxide/cGMP pathway. The use with the soluble guanylate cyclase (sGC) stimulator riociguat is also strictly contraindicated, as this combination significantly lowers blood pressure.

Caution and Dose Adjustments

  • CYP3A4 Inhibitors: Sildenafil is primarily metabolized by the enzyme CYP3A4. Concomitant use with strong inhibitors of this enzyme, such as ritonavir, ketoconazole, or erythromycin, increases sildenafil plasma levels and exposure. A lower starting dose (e.g., 25 mg) should be considered, and for potent inhibitors like ritonavir, the dosage is significantly restricted (e.g., maximum 25 mg over 48 hours).
  • Alpha-Blockers: Caution is advised when sildenafil is co-administered with alpha-blockers (used for hypertension or prostate issues) due to the risk of symptomatic hypotension. Patients should be hemodynamically stable on alpha-blocker therapy before initiating sildenafil, and a 25 mg starting dose is recommended to minimize this risk, which is most likely to occur within four hours of dosing.
  • Other Antihypertensives: Sildenafil has systemic vasodilatory properties and may have an additive blood pressure-lowering effect with other antihypertensive agents, including amlodipine.
Advertisements

Mechanism of Action

Selective Protection of the cGMP Messenger

Sildenafil operates as a selective inhibitor of the Phosphodiesterase type 5 (PDE5) enzyme, a biological target involved in regulating vascular smooth muscle tone. By binding competitively to the enzyme, the drug prevents the rapid breakdown of the chemical messenger cGMP, a compound that signals smooth muscle relaxation. This action increases the intracellular concentration of cGMP.


Amplification of the Nitric Oxide Signaling Cascade

The drug's mechanism hinges upon the Nitric Oxide (NO)-cGMP pathway and is entirely stimulus-dependent. Sildenafil only amplifies the natural signal initiated by NO release, amplifying the resultant cGMP levels, which facilitates vasodilation (vessel widening) and increased local blood flow in targeted vascular areas.


Mechanistic Constraint and Selectivity Limits

Sildenafil’s mechanism has a known limitation involving cross-reactivity with the related PDE6 enzyme, found predominantly in the retina. This less-selective action on the phototransduction cascade is an inherent aspect of the drug’s chemical profile, which results in a mechanistic interference with targeted PDE5 inhibition.

Advertisements

Dosage and Administration Information

General Administration Principles

Sildenafil administration follows two distinct protocols, dependent on the condition being addressed: Intermittent Use and Chronic Maintenance Use. The primary administration route for both protocols is oral, typically using film-coated tablets. However, an intravenous (IV) injection is available for chronic maintenance use when the patient is temporarily unable to take the oral dose.


Protocol 1: Intermittent Use (As Needed)

The standard regimen for intermittent administration begins with a starting dose of 50 mg, with the established dose range spanning from 25 mg to 100 mg. The maximum frequency for this protocol is once per day. Administration occurs as needed, typically 30 minutes to 4 hours prior to activity. Ingestion with a high-fat meal may delay the time until peak concentration is achieved. For specific groups, including older adults (65 years or older) or patients with severe renal or hepatic impairment, a lower starting dose of 25 mg is utilized.


Protocol 2: Chronic Maintenance Use

For chronic maintenance, Sildenafil is administered on a fixed schedule of three times daily (TID), with doses spaced approximately 4 to 6 hours apart. The usual dose is 20 mg, with titration permitted up to a maximum of 80 mg per dose based on clinical need. The oral forms may be taken with or without food. If the oral suspension is prescribed, specific reconstitution with water is required prior to administration. If a dose is missed, it must be taken as soon as possible, and subsequent doses should then return to the regular fixed schedule.

Advertisements

Recent Clinical Evidence

Recent Clinical Evidence Overview

Clinical trials involving sildenafil have primarily focused on two distinct conditions: Erectile Dysfunction (ED) and Pulmonary Arterial Hypertension (PAH). Research continues to explore the effects of this medication in various patient populations and its influence on long-term clinical outcomes.


Erectile Dysfunction (ED) Studies

Studies examined the effects of sildenafil on the ability to achieve and maintain an erection sufficient for sexual activity. Efficacy was measured using patient-reported outcome tools, such as the International Index of Erectile Function (IIEF). In placebo-controlled trials, men receiving sildenafil were observed to have a higher percentage of successful sexual intercourse attempts compared to those receiving placebo. Research also evaluated the impact on the overall satisfaction domain of the IIEF questionnaire. The effect was observed across various subgroups, including men with ED associated with diabetes mellitus or post-prostatectomy.


Pulmonary Arterial Hypertension (PAH) Studies

Research has explored the effects of sildenafil on exercise capacity in adults with PAH. The principal endpoint measured in key trials was the 6-minute walk distance (6MWD). Studies monitored whether there was a change in the 6MWD compared to baseline and against a placebo group, with results typically showing an increase in the distance walked. Other hemodynamic parameters evaluated included mean pulmonary arterial pressure (mPAP) and pulmonary vascular resistance (PVR). Long-term extension studies continue to track the effects of this therapy on the time to clinical worsening in adult and pediatric populations.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Aladin (Sildenafil) (FAQ)


Q: How quickly does Aladin (Sildenafil) start working for most people?

Official drug information indicates that the time it takes for the drug to reach its maximum plasma concentration in the bloodstream is typically about one hour. This peak concentration indicates the time when the amount of active substance in the body is highest, which is generally associated with the onset of the medicine's therapeutic action.


Q: Can Aladin (Sildenafil) be affected by food or meals?

Yes, the drug's absorption can be influenced by food intake. Regulatory documents state that taking the medicine with a high-fat meal may delay the time it takes to reach its maximum concentration in the blood. For regimens where the drug is taken regularly (chronic use), official documents indicate the oral forms may be taken with or without food.


Q: Can Aladin (Sildenafil) interact with high blood pressure medicines?

Official product information describes that Sildenafil has properties that cause vasodilation (widening of blood vessels). Because of this, when Sildenafil is co-administered with other medicines used to treat high blood pressure, an additive blood pressure-lowering effect may occur. This potential for interaction is why the safety sections of the prescribing information include a warning.


Q: Are there any common over-the-counter supplements that interact with Aladin (Sildenafil)?

The regulatory summary notes a requirement for caution regarding substances that are strong inhibitors of the CYP3A4 enzyme. Since this enzyme is primarily responsible for breaking down Sildenafil in the body, its inhibition can lead to increased Sildenafil levels in the bloodstream. This category includes certain prescription medicines, but also some herbal or over-the-counter supplements.


Q: Are there specific official warnings about using Aladin (Sildenafil) with alcohol?

Yes, official documents note that Sildenafil can lower blood pressure. The concurrent use of alcohol may further increase this effect. This combination could potentially increase the risk of experiencing symptoms associated with low blood pressure, such as lightheadedness or dizziness.


Q: Are generic versions of Sildenafil less effective than brand-name Aladin?

Regulatory agencies require that all approved generic versions meet bioequivalence standards when compared to the original brand-name product. Bioequivalence means the generic drug must deliver the same amount of active ingredient into the bloodstream over the same period of time. This regulatory requirement is in place to establish that the generic medicine is comparable to the brand-name medicine.


Q: Can I use Aladin (Sildenafil) if I have kidney problems?

Official prescribing information addresses use in populations with kidney issues. For patients who have impaired renal function, especially severe impairment, monitoring of kidney function may be required. Regulatory documents also note that a lower starting dose may be indicated for these populations.


Q: What are the official clinical reasons for stopping use of Aladin (Sildenafil)?

Official safety documents list certain serious adverse reactions which are conditions that necessitate prompt clinical evaluation and may lead to stopping the medicine. These reactions include a sudden decrease or loss of vision, sudden hearing loss, or a priapism (a prolonged erection lasting over four hours).


Q: Is it safe to use Aladin (Sildenafil) if you have glaucoma?

Official documents describe potential visual disturbances, such as blurred vision or a color tinge to vision, as known side effects. Regulatory bodies include warnings for patients with certain pre-existing eye conditions in the prescribing information.


Q: Does Aladin (Sildenafil) have any known interaction with grapefruit juice?

Yes, official prescribing information advises caution regarding grapefruit juice. This is because grapefruit juice may increase the amount of Sildenafil in the bloodstream and delay its absorption. Due to this potential interaction, the combination is often advised against in official information.


Q: What research exists about Sildenafil's effect on heart rate?

While Sildenafil is generally associated with vascular effects, regulatory adverse reaction reports cite rare, serious cardiovascular events in temporal association with its use. These have included irregular heartbeat, myocardial infarction, and sudden cardiac death.


Q: What is the typical duration of effect for Aladin (Sildenafil)?

Pharmacokinetic data indicates that Sildenafil has a terminal half-life ranging between three and five hours. The half-life is the time required for the amount of drug in the body to be reduced by half. Clinical data indicates that the therapeutic response has been observed over a period of several hours following administration.


Q: Do you need a prescription for Aladin (Sildenafil) in most places?

Yes, the regulatory classification of Sildenafil in most major global markets, including the US and EU, is as a prescription-only medicine. This classification means a healthcare professional must authorize its use for its approved indications.


Q: Is Aladin (Sildenafil) appropriate for older adults?

Official prescribing information indicates that use is permitted for older adults (aged 65 years or older). However, a lower starting dose may be indicated for this population compared to younger adults, as is described in the regulatory documents.


Q: Can women use Aladin (Sildenafil)?

The answer depends on the condition being treated. While Sildenafil is not indicated for women for the treatment of erectile dysfunction, it is approved for use by both women and men for the treatment of Pulmonary Arterial Hypertension (PAH).


Q: Is there any research on long-term effects of using Aladin (Sildenafil)?

Yes, regulatory documents cite long-term open-label extension studies that have examined the medicine. These studies tracked the drug's tolerability and the incidence of adverse events over a period of multiple years.


Q: Does Aladin (Sildenafil) still work if you have diabetes?

Clinical research has examined the effectiveness of Sildenafil for erectile dysfunction in patients who also have diabetes mellitus. These studies reported positive outcomes, indicating the medicine’s utility in this patient group.


Q: What does 'maximum plasma concentration' mean for Sildenafil?

This is a term used in regulatory documents to describe the highest amount of the drug that is present in the bloodstream after a dose has been taken. It is often referred to by the abbreviation C max in pharmacological data.


Q: Why is Aladin (Sildenafil) not recommended for everyone with erectile issues?

Official drug information specifies certain absolute contraindications that prevent use in some individuals. These include conditions like taking organic nitrates, having a history of vision loss due to NAION, or having certain severe cardiovascular conditions.


Q: Is there a maximum recommended frequency for taking Aladin (Sildenafil)?

The maximum recommended frequency for taking the medicine is strictly defined and varies based on the approved use (either as-needed or chronic maintenance). The specific limitations are set forth in the prescribing information for each protocol.


Q: Are there any official restrictions on driving or operating machinery while using Aladin (Sildenafil)?

Official prescribing information notes that caution is warranted regarding performing skilled tasks. This warning is due to potential side effects like dizziness, blurred vision, or changes in vision that have been reported and which could potentially impair the ability to operate machinery or drive.


Q: Can Aladin (Sildenafil) be taken by people with sickle cell disease?

Caution is required for populations that are predisposed to a serious condition called priapism (a prolonged erection). Because of this risk, Sildenafil is generally not recommended in some patients with underlying conditions such as sickle cell anemia.

Advertisements

How should Aladin (Sildenafil) be stored and disposed of?

How to Store and Dispose of Aladin (Sildenafil)?

Sildenafil tablets must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F). The medication should be kept in the original container and the container must be tightly closed to maintain stability.

Child-Safety Storage

To prevent accidental ingestion, sildenafil must be stored out of the sight and reach of children.

Official Disposal Rules

The preferred method for disposing of unused or expired sildenafil is via a drug take-back program. If a take-back program is not available, the tablets must be mixed with an undesirable substance like dirt or cat litter, placed in a sealed container, and then discarded in the household trash. Sildenafil is not on the list of medicines recommended for flushing down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Aladin (Sildenafil) found in:

A-Z Index: